Affiliation:
1. European Biomedical Research Institute of Salerno (EBRIS), Salerno, Italy
Abstract
Artificial intelligence methods, in particular, machine learning, has been playing
a pivotal role in drug development, from structural design to the clinical trial. This approach
is harnessing the impact of computer-aided drug discovery due to large available
data sets for drug candidates and its new and complex manner of information interpretation
to identify patterns for the study scope. In the present review, recent applications related
to drug discovery and therapies are assessed, and limitations and future perspectives
are analyzed.
Publisher
Bentham Science Publishers Ltd.
Subject
Pharmacology,Molecular Medicine,Drug Discovery,Biochemistry,Organic Chemistry
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献